HORIZON
CarrerasPathfinders
Enabling the next generation in search of blood cancer cures
- Programme
- Horizon Europe
- Started
- Ends
- Duration
- 60 months
- Total cost
- Not stated
- EU contribution
- EUR 1,881,600
- Participants
- 20 from 11 countries
- Topic
- HORIZON_HORIZON-MSCA-2022-COFUND-01-01
- Grant agreement
- 101126688
Consortium
EU contribution per participant as the open data of CORDIS states it; for a participant with linked third parties it may include their share, and a participant whose amount the data does not hold or cannot make consistent shows Not stated. A participant who left the project is not listed; see the history below.
| Organisation | Country | Role | EU contribution | Recognised by |
|---|---|---|---|---|
| University of Sharjah | AEUnited Arab Emirates | Associated partner | EUR 0 | PIC (1.00) |
| Specialized Hospital for Active Treatment of Hematological Diseases | BGBulgaria | Associated partner | EUR 0 | PIC (1.00) |
| Fondazione Per L'Istituto Oncologico di Ricerca (Ior) | CHSwitzerland | Associated partner | EUR 0 | known name (0.95) |
| Charite - Universitaetsmedizin Berlin | DEGermany | Associated partner | EUR 0 | PIC (1.00) |
| Applied Research Using Omic Sciences SL | ESSpain | Associated partner | EUR 0 | PIC (1.00) |
| Asociacion Eit Health Spain | ESSpain | Associated partner | EUR 0 | PIC (1.00) |
| Biocat la Fundacio Bioregio de Catalunya | ESSpain | Associated partner | EUR 0 | known name (0.95) |
| Fundacion Cientifica de la Asociación Espanola Contra El Cancer | ESSpain | Associated partner | EUR 0 | PIC (1.00) |
| Mesoestetic Pharma Group S.L. | ESSpain | Associated partner | EUR 0 | PIC (1.00) |
| Onechain Immunotherapeutics S.L. | ESSpain | Associated partner | EUR 0 | PIC (1.00) |
| Quimatryx SL | ESSpain | Associated partner | EUR 0 | PIC (1.00) |
| Novogene UK Company Limited | GBUnited Kingdom | Associated partner | EUR 0 | PIC (1.00) |
| Humanitas Mirasole SpA | ITItaly | Associated partner | EUR 0 | PIC (1.00) |
| European Hematology Association | NLNetherlands | Associated partner | EUR 0 | PIC (1.00) |
| Fundacao Gimm - Gulbenkian Institute for Molecular Medicine | PTPortugal | Associated partner | EUR 0 | known name (0.95) |
| Institutul National de Cercetare - Dezvoltare in Domeniul Patologiei Si Stiintelor Biomedicale Victor Babes Ra | RORomania | Associated partner | EUR 0 | PIC (1.00) |
| International Society for Experimental Hematology | USUnited States | Associated partner | EUR 0 | PIC (1.00) |
| New York University | USUnited States | Associated partner | EUR 0 | PIC (1.00) |
| Trustees of Columbia University in the City of New York | USUnited States | Associated partner | EUR 0 | PIC (1.00) |
| Name not shown | Not stated | Associated partner | Not stated | PIC (1.00) |
Changes of the consortium
First seen on with 20 participants from 11 countries.
A snapshot of each project's members is taken once a month; a change is recorded when a snapshot differs from the one before. A project with no change listed has had the same members since it was first observed.
Project page on CORDIS (opens in new tab)
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them.
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.